Citation: | YAN Su, LI Bin, MA Xuxiang, MA Yingcai, XIONG Yuanzhi, GUO Xinjian, MA Yubin, YU Pengjie, WU Junqi, XIE Dawei, ZHAO Junhui, WU Huixian. Clinicopathological Characteristics of Young Gastric Cancer Patients in Hehuang Valley[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 502-505. DOI: 10.3971/j.issn.1000-8578.2015.05.018 |
[1] |
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009[J]. CA Cancer J Clin, 2009, 59(4): 225-49.
|
[2] |
Parkin DM. International variation[J]. Oncogene, 2004, 23(38): 63 29-40.
|
[3] |
Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture[J]. Eur J Cancer, 2001, 37 Suppl 8: S4-66.
|
[4] |
Yan S, Li, B, Wu JQ, et al. Analysis of characteristics of clinical epidemiology about gastric cancer in Hehuang Valley[J]. Zhongguo Ai Zheng Za Zhi, 2014, 24(4): 246-51.[燕速, 李斌, 吴 俊麒, 等. 河湟谷地胃癌临床流行病学特征分析[J]. 中国癌症杂 志, 2014, 24(4): 246-51.]
|
[5] |
Yan S, Li B, Wu JQ, et al. Changes in the clinicopathological characteristics of gastric cancer in Hehuang Valley of China-2379 cases of gastric cancer in recent 10 years[J]. Chinese-German J Clin Oncol, 2014, 13(2): 63-8.
|
[6] |
Smith BR, Stabile BE. Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young[J]. Arch Surg, 2009, 14 4(6): 506-10.
|
[7] |
Snatoro R, Carboni F, Lepiane P, et al. Clinicopathological features and prognosis of gastric cancer in young European adults[J]. Br J Surg, 2007, 94(6): 737-42.
|
[8] |
Karami N, Talebkhan Y, Saberi S, et al. Seroreactivity to Helicobacter pylori antigens as a risk indicator of gastric cancer [J]. Asian Pac J Cancer Prev, 2013, 14(3): 1813-7.
|
[9] |
Hofmann M, Stoss O, Shi D, et al. Assessment of a HER2 scoring system for gastric cancer: results from a validation study[J]. Histopathology, 2008, 52(7): 797-805.
|
[10] |
Mrklic I, Bendic A, Kunac N, et al. Her-2/neu assessment for gastric carcinoma: validation of scoring system[J]. Hepatogastroenterology, 2012, 59(113): 300-3.
|
[11] |
Bai Y, Li ZS. Endoscopic, clinicopathological features and prognosis of very young patients with gastric cancer[J]. J Gastroenterol Hepatol, 2011, 26(11): 1626-9.
|
[12] |
Saito H, Osaki T, Murakami D, et al. Effect of age on prognosis in patients with gastric cancer[J]. ANZ J Surg, 2006, 76(6): 458-61.
|
[13] |
Choi JH, Chung HC, Yoo NC, et al. Gastric cancer in young patients who underwent curative resection. Comparative study with older patients[J]. Am J Clin Oncol, 1996, 19(1): 45-8.
|
[14] |
Hsieh FJ, Wang YC, Hsu JT, et al. Clinicopathological features and prognostic factors of gastric cancer patients aged 40 years or younger[J]. J Surg Oncol, 2012, 105(3): 304-9.
|
[15] |
López-Basave HN, Morales-Vásquez F, Ruiz-Molina JM, et al. Gastric cancer in young people under 30 years of age: worse prognosis, or delay in diagnosis?[J]. Cancer Manag Res, 2013, 5: 31-6.
|
[16] |
Koea JB, Karpeh MS, Brennan MF. Gastric cancer in young patients: demographic, clinicopathological, and prognostic factors in 92 patients[J]. Ann Surg Oncol, 2000, 7(5): 346-51.
|
[17] |
Hirano S, Nose A, Hatta K, et al. Calcium-dependent cell-cell adhesion molecules (cadherins): subclass specificities and possible involvement of actin bundles[J]. J Cell Biol, 1987, 105(6 Pt 1): 25 01-10.
|
[18] |
Gayther SA, Gorringe KL, Ramus SJ, et al. Identification of germline E-cadherin mutations in gastric cancer families of European origin[J]. Cancer Res, 1998, 58(18): 4086-9.
|